ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 120 filers reported holding ALBANY MOLECULAR RESH INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $966,000 | -32.6% | 44,419 | -48.9% | 0.00% | -25.0% |
| Q3 2016 | $1,434,000 | +8.8% | 86,850 | -11.4% | 0.00% | 0.0% |
| Q2 2016 | $1,318,000 | -18.9% | 98,079 | -7.8% | 0.00% | -20.0% |
| Q1 2016 | $1,626,000 | -41.4% | 106,388 | -23.9% | 0.01% | -37.5% |
| Q4 2015 | $2,775,000 | +14.5% | 139,789 | +0.5% | 0.01% | +14.3% |
| Q3 2015 | $2,423,000 | -14.6% | 139,098 | -0.8% | 0.01% | 0.0% |
| Q2 2015 | $2,837,000 | +38.1% | 140,257 | +20.1% | 0.01% | +40.0% |
| Q1 2015 | $2,055,000 | +33.1% | 116,756 | +23.1% | 0.01% | +25.0% |
| Q4 2014 | $1,544,000 | -24.2% | 94,843 | +2.7% | 0.00% | -20.0% |
| Q3 2014 | $2,038,000 | -11.4% | 92,364 | -19.2% | 0.01% | -16.7% |
| Q2 2014 | $2,299,000 | -9.5% | 114,266 | -16.4% | 0.01% | -14.3% |
| Q1 2014 | $2,540,000 | +30.1% | 136,635 | -29.4% | 0.01% | +16.7% |
| Q4 2013 | $1,952,000 | – | 193,659 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 567,400 | $11,473,000 | 12.05% |
| Permian Investment Partners, LP | 1,875,650 | $37,926,000 | 7.67% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 1,490,174 | $30,131,000 | 2.57% |
| AMERICAN CAPITAL MANAGEMENT INC | 993,280 | $20,084,000 | 1.91% |
| Netols Asset Management, Inc. | 387,471 | $7,835,000 | 1.54% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,158,759 | $23,430,000 | 1.35% |
| Evercore Wealth Management, LLC | 1,233,880 | $24,948,000 | 1.13% |
| Visium Asset Management, LP | 3,200,000 | $64,704,000 | 0.92% |
| Granite Investment Partners, LLC | 303,787 | $6,143,000 | 0.57% |
| FRANKLIN STREET ADVISORS INC /NC | 144,125 | $2,914,000 | 0.52% |